Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?

References

• Kavanaugh AF, Solomon DH. American College of Rheu-matology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002;47:546–555.
   Google Scholar
• Hochberg MC. Updating the American College of Rheu-matology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Hahn BH, Tsao BP. Antibodies to DNA. In: Wallace DJ, Breva HH, editors. Dubois' Lupus Erythematosus. Philadelphia: Lippincott Williams & Wilkins; 2002. p 425–445.
   Google Scholar
• Peeva E, Diamond B. Anti-DNA antibodies: structure, assembly and diversity. In: Lahita RG, editor. Systemic Lupus Erythematosus. Oxford: Elsevier, 2004. p 283–314.
   Google Scholar
• Smeenk RJT. Detection of antibodies to dsDNA: current insights into its relevance. Clin Exp Rheumatol 2002;20:294–300.
   PubMedGoogle Scholar
• Smeenk RJT, Berden JHM, Swaak AJG. dsDNA autoanti-bodies. In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Oxford: Elsevier; 1996. p 227–236.
   Google Scholar
• Rekvig OP, Nossent JC. Anti-double-stranded DNA anti-bodies, nucleosomes, and systemic lupus erythematosus. Arthritis Rheum 2003;48:300–312.
   PubMedGoogle Scholar
• Rahman A. Autoantibodies, lupus and the science of sabotage. Rheumatology 2004; Aug. 24 [Epub ahead of print].
   Google Scholar
• Riboldi P, Kasaian MT, Mantovani L, Ikematsu H, Casali P. Natural antibodies. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, editors. The molecular pathology of autoimmune diseases. Chur: Harwood Academic Publishers, 1993. p 45–64.
   Google Scholar
• Manson jj,Isenberg DA. The pathogenesis of systemic lupus erythematosus. Neth J Med 2003;61:343–346.
   PubMed Web of Science ®Google Scholar
• Fritzler MJ. New technologies in the detection of autoanti-bodies: evaluation of addressable laser bead immunoassays (ALBIA). In: Conrad K, Bachmann MP, Chan EKL, Fritzler MJ, Humbel RL, Sack U, Shoenfeld Y, editors. From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies. Lengerich: Pabst Science Publisher, 2004; p 449–459.
   Google Scholar
• Prestigiacomo T, Humbel RL,, Larida B, Binder SR. Multiplexed analysis of thirteen autoantibodies using the BioPlex" 2200 fully automated immunoassay analyser. In: Conrad K, Bachmann MP, Chan EKL, Fritzler MJ, Humbel RL,, Sack U, Shoenfeld Y, editors. From animal models to human henetics: Research on the induction and pathogenicity of autoantibodies. Lengerich: Pabst Science Publisher; 2004. p 463–466.
   Google Scholar
• Utz PJ, Chan SM. Autoantibody profiling and lymphocyte characterization using autoantigen and lysate arrays. In: Conrad K, Bachmann MP, Chan EKL, Fritzler MJ, Humbel RL, Sack U, Shoenfeld Y, editors. From animal models to Human Genetics: Research on the induction and pathogenicity of autoantibodies. Lengerich: Pabst Science Publisher; 2004. p 473–483.
   Google Scholar
• Hentschel Ch, Schoessler W, Schulte-Pelkum J, Kreutzberger J, Hiepe F. Development of a sensitive and reliable Biochip for detection of autoantibodies in rheumatic diseases. In: ConradK, Bachmann MP, Chan EKL, Fritzler MJ, Humbel RL,, Sack U, Shoenfeld Y, editors. From animal models to human genetics: Research on the induction and pathogenicity of autoantibodies. Lengerich: Pabst Science Publisher; 2004. p 484–489.
   Google Scholar
• Hylkema MN, Van Bruggen MC, ten Hove T, de Jong J, Swaak AJ, Berden JH, et al. Histone-containing immune complexesare to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients. J Autoimmun 2000;14:159–168.
   PubMedGoogle Scholar
• Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985;44:245–251.
   PubMed Web of Science ®Google Scholar
• Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995;345:1595–1599
   Google Scholar
• Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937–944.
   PubMed Web of Science ®Google Scholar
• Esdaile JM, Abrahamowicz M, Joseph L, MacKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerba-tions in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum 1996;39:370–378.
   PubMed Web of Science ®Google Scholar
• Walz LeBlanc BA, Gladman DD, Urowitz MB. Sero-logically active clinically quiescent systemic lupus erythe-matosus-predictors of clinical flares. J Rheumatol 1994;21:2239–2241.
   Google Scholar
• Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, et al. Anti-Clq antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001;37:490–498.
   PubMed Web of Science ®Google Scholar
• Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000;43:76–84.
   PubMed Web of Science ®Google Scholar
• Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 2004;43:220–224.
   Google Scholar
• American college of Rheumatology ad hoc committee on immunologic testing guidelines Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Care Res 2002;47:429–433.
   Google Scholar
• Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythe-matosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identi-fication of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Chin Exp Rheumatol 1992;10:541–547.
   Google Scholar
• Sugisaki T, Takase S. Composition of immune deposits present in glomeruli of NZB/W Fl mice. Chin Immunol Immunopatol 1991;61:296–308.
   PubMedGoogle Scholar
• Kramers C, Hylkema MN, Van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Chin Investig 1994;94:568–577.
   Google Scholar
• Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz 0. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 1987;138:2883–2889.
   Google Scholar
• Ehrenstein MR, Katz DR, Griffiths MH, Papadaki L, Winkler TH, Kalden JR, et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 1995;48:705–711.
   PubMed Web of Science ®Google Scholar
• Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989;142:3076–3082.
   PubMed Web of Science ®Google Scholar